Effect of buspirone on iatrogenic dyskinesias of advanced Parkinson's disease. Phase II, international, double-blind, controlled, placebo-controlled, multicentre trial in two parallel groups.

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Gilles
Principal Investigator Last Name
FENELON
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
$128,824
Funding Organization